8-K: Community Healthcare Trust Upsizes Credit Facility to $400 Million, Extends Maturity
Debt Refinancing Announcement
Community Healthcare Trust has increased its revolving credit facility to $400 million and extended the maturity date to 2029, while also achieving lower interest rates.
Summary
- Community Healthcare Trust has amended its credit agreement, increasing its revolving credit facility from $150 million to $400 million.
- The maturity date of the revolving credit facility has been extended from March 19, 2026, to October 16, 2029.
- The interest rate on the revolving credit facility has been reduced by 10 to 30 basis points, depending on the company's leverage ratio.
- Proceeds from the increased facility were used to repay a $75 million term loan due in 2026.
- Approximately $123 million outstanding under the previous revolving facility will remain outstanding under the amended facility.
- The amended credit agreement allows the company to borrow up to $875 million, including incremental term loans, through an accordion feature.
- Interest rates on the revolving facility will be based on either adjusted term SOFR or adjusted daily simple SOFR plus 1.15% to 1.75%, or a base rate plus 0.15% to 0.75%, depending on the company's leverage ratio.
- Existing term loans will continue to bear interest at a floating rate based on adjusted term SOFR or adjusted daily simple SOFR plus 1.65% to 2.30%, or a base rate plus 0.65% to 1.30%, depending on the company's leverage ratio.
- The company has interest rate swaps in place to fix rates on existing term loans, with swaps on the repaid term loan remaining in place to fix rates on a portion of the new revolving facility.
Sentiment
Score: 8
Explanation: The document is very positive, highlighting increased liquidity, extended maturity, and lower interest rates. This is a strong positive for the company's financial health and future prospects.
Positives
- The company has significantly increased its liquidity with the upsized credit facility.
- The extended maturity profile pushes the next debt maturity to March 2028.
- The company has secured improved, lower pricing on the revolving credit facility.
Risks
- The document mentions risks related to general volatility of capital markets, changes in business strategy, and the ability to refinance existing debt, which are standard risks for a company in this sector.
- The document also mentions risks related to the healthcare industry, governmental regulations, competition, and the impact of weather and climate change, which are also standard risks for a company in this sector.
Future Outlook
The company intends to use the increased liquidity to finance future acquisitions, working capital needs, and for other general corporate purposes.
Management Comments
- The amended $400 million Revolving Facility will significantly increase the Company’s liquidity compared to the previous $150 million senior unsecured revolving line of credit.
- This Refinancing Transaction extends the Company’s debt maturity profile with the next debt maturity not being until March 2028.
- The Company also achieved improved, lower pricing on the Revolving Facility of 10 to 30 basis points depending on the applicable leverage ratio.
Industry Context
This announcement reflects a trend in the healthcare REIT sector to secure favorable financing terms and extend debt maturities, which is a positive sign for the company's financial stability and growth prospects.
Comparison to Industry Standards
- Many healthcare REITs utilize revolving credit facilities to manage short-term liquidity needs and fund acquisitions.
- The size of the facility and the interest rate terms are comparable to those of other mid-sized healthcare REITs.
- Extending the maturity profile is a common strategy to reduce refinancing risk and improve long-term financial planning.
- Companies like Welltower (WELL) and Ventas (VTR) also use similar financing strategies, but their scale and credit ratings may result in different terms.
- The specific interest rate terms are dependent on the company's leverage ratio, which is a standard practice in credit agreements.
Stakeholder Impact
- Shareholders will likely view this as a positive development, as it improves the company's financial flexibility and reduces refinancing risk.
- Employees may benefit from the company's improved financial stability.
- Customers and suppliers may see this as a sign of the company's long-term viability.
Next Steps
- The company will use the increased liquidity to finance future acquisitions and for general corporate purposes.
- The company will continue to manage its debt profile and leverage ratio.
Key Dates
| Date | Description |
|---|---|
| 2021-03-19 | Date of the Third Amended and Restated Credit Agreement. |
| 2022-12-14 | First Amendment Date of the Third Amended and Restated Credit Agreement. |
| 2024-10-16 | Date of the Second Amendment to the Third Amended and Restated Credit Agreement, upsizing the credit facility and extending the maturity. |
| 2026-03-29 | Original maturity date of the repaid $75 million term loan. |
| 2028-03-19 | Maturity date of the existing seven-year term loan facility (A-4 Term Loan). |
| 2029-10-16 | New maturity date of the revolving credit facility. |
| 2030-03-14 | Maturity date of the existing seven-year and three-month term loan facility (A-5 Term Loan). |
Keywords
credit facility, revolving credit, debt financing, interest rates, maturity extension, healthcare REIT, senior unsecured, liquidity, term loan, SOFR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.